Pediatrics
Partner With Us
Advertisement
Conexiant chevron_right Pediatrics chevron_right Montelukast Safety in Neuropsychiatric Risks Study in Children
From the Journals

Montelukast Safety in Neuropsychiatric Risks: Study in Children

A large cohort study finds no link between montelukast use and neuropsychiatric adverse events in children, supporting its safety for asthma and allergic rhinitis management.

Conexiant
article Full Article subject Summary summarize Notecard
  1. Montelukast use in pediatric and adolescent patients not linked to increased neuropsychiatric adverse events.
  2. Study compared montelukast users with long-acting beta-agonist users.
  3. Nationwide Swedish register data used for the cohort study.
  4. No statistically significant differences in secondary outcomes between the groups.
  5. Montelukast use not associated with increased risk of neuropsychiatric adverse events in this population.

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.